Results 171 to 180 of about 5,435,053 (210)

Epidemiology of Biopsy-Proven Giant Cell Arteritis (GCA)

Journal of Internal Medicine, 1990
Abstract. During a 10‐year period from 1st January 1977 to 31st December 1986, a temporal artery biopsy was performed in 2307 patients in the city of Göteborg. The biopsy revealed giant cell arteritis (GCA) in 284 (12.5%) of patients. The average annual incidence of biopsy‐proven GCA was 6.7 per 100 000 inhabitants.
E Nordborg, B A Bengtsson
exaly   +3 more sources

Blinded Search for Varicella Zoster Virus in Giant Cell Arteritis (GCA)-Positive and GCA-Negative Temporal Arteries [PDF]

Journal of the Neurological Sciences, 2016
Recent analysis of archived temporal arteries (TAs) acquired from 13 pathology laboratories in the US, Canada, Iceland, France, Germany and Israel from patients with pathologically-verified giant cell arteritis (GCA-positive) and TAs from patients with clinical features and laboratory abnormalities of GCA but whose TAs were pathologically negative (GCA-
Bradley J Katz, Maria A Nagel, Don Gilden   +2 more
exaly   +3 more sources

Giant Cell Arteritis (GCA) as a Risk Factor for Seizures: A Cohort Study

Postgraduate Medicine
The objective of this study was to assess the risk of seizures in Giant Cell Arteritis (GCA) patients in a large cohort of Israeli subjects, in comparison to matched controls. Patients diagnosed with GCA between 2002 and 2017 were included. Controls were matched based on sex, age, socioeconomic status, country of birth, diabetes mellitus, and ...
Abdulla Watad, Avishai Tsur, Omer Gendelman   +2 more
exaly   +3 more sources

Tongue Necrosis as First Symptom of Giant Cell Arteritis (GCA)

Clinical Rheumatology, 2009
Giant cell arteritis (GCA) is the most common systemic vasculitis affecting people over the age of 50 years, especially in the western world. Nevertheless, the initial diagnosis can be tricky, as some of the patients present at first time with a real unusual initial manifestation.
M, Brodmann, A, Dorr, F, Hafner, T, Gary, E, Pilger   +4 more
exaly   +3 more sources

SAT0365 Risk Factors for Visual Loss in Giant Cell Arteritis (GCA)

Annals of the Rheumatic Diseases, 2016
Background visual loss is the most frequent ischemic complication and the main cause of permanent disability among patients with GCA. To identify factors related to this complication may help physicians to start an early treatment and assay new therapies Objectives To analyse clinical and histological findings related to visual loss in patients with
R. Solans-Laqué, G. Fraile, B. Escalante, E. Fonseca, A. Martinez-Zapico, M. Perez-Conesa, M. Abdilla, M. Montegaudo, L. Caminal, B. Gracia, M.J. Del Castillo, P. Fanlo, M. Ramentol   +12 more
openaire   +1 more source

The Management of Giant Cell Arteritis (GCA) Overlapping With Sjogren Syndrome : A Case Report

Indian Journal of Forensic Medicine and Toxicology (discontinued), 2022
Giant cell arteritis (GCA) is an autoimmune vasculitis involving large and medium arteries. GCA israrely associated with autoimmune diseases, such as Sjögren’s syndrome. Glucocorticoids (GC) arethe cornerstone of the treatment of GCA as they are very effective but are often given for 1 year toavoid relapses.
null Arina Mana Sikana, null Awalia
exaly   +2 more sources

AB0739 Giant cell arteritis (GCA): Are we following current european guidelines?

Annals of the Rheumatic Diseases, 2012
Background GCA is the most common primary systemic vasculitis associated with siginificant morbidity. Guidance on management have been issued by the British Society for Rheumatology (BSR) and European League Against Rheumatism (EULAR). Objectives We as a rheumatology department wished to identify if our current practice in diagnosing and managing ...
A. Tan, T. Chee, M. Lambert, N. Amft
openaire   +1 more source

AB0600 How do General Practitioners Identify GIANT Cell Arteritis (GCA)?

Annals of the Rheumatic Diseases, 2014
Background Giant Cell Arteritis (GCA) is the commonest large vessel vasculitis yet a full time UK general practitioner (GP) can expect to see just 1 case every 1-2 years [Barraclough]. GCA may be difficult to identify, particularly in atypical cases.
T. Helliwell, S. Muller, S.L. Hider, J. Richardson, C. Mallen   +4 more
openaire   +1 more source

Management guidelines and outcome measures in giant cell arteritis (GCA).

Clinical and experimental rheumatology, 2008
Giant cell arteritis (GCA) is a common form of vasculitis that predominantly affects the elderly. Cranial symptoms and elevated inflammatory markers are suggestive of the condition and the diagnosis is usually established by temporal artery biopsy. Corticosteroids are the mainstay of treatment for GCA and prolonged therapy is often necessary.
K J, Warrington, E L, Matteson
openaire   +1 more source

Characteristics associated with anterior ischemic optic neuropathy (AION) in giant cell arteritis (GCA)

Clinical Rheumatology
Giant cell arteritis (GCA) is the most common vasculitis and can result in blindness due to anterior ischemic optic neuropathy (AION). Little is known about which patients with GCA are at higher risk of AION.  We did a retrospective chart review to compare demographics, past medical history, labs and imaging of GCA patients with and without AION.All ...
Jenna L. Thomason, Ingeborg Sacksen, R. Eugene Zierler, Courtney E. Francis, P. Scott Pollock, Alison M. Bays   +5 more
openaire   +2 more sources